- Home
- ROIC vs AGIO Comparison
ROIC vs AGIO Comparison
Compare ROIC & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIC
- AGIO
- Stock Information
- Founded
- ROIC 2007
- AGIO 2007
- Country
- ROIC United States
- AGIO United States
- Employees
- ROIC N/A
- AGIO N/A
- Industry
- ROIC Real Estate Investment Trusts
- AGIO Biotechnology: Pharmaceutical Preparations
- Sector
- ROIC Real Estate
- AGIO Health Care
- Exchange
- ROIC Nasdaq
- AGIO Nasdaq
- Market Cap
- ROIC 2.0B
- AGIO 2.4B
- IPO Year
- ROIC N/A
- AGIO 2013
- Fundamental
- Price
- ROIC $16.07
- AGIO $44.14
- Analyst Decision
- ROIC Hold
- AGIO Buy
- Analyst Count
- ROIC 4
- AGIO 7
- Target Price
- ROIC $15.00
- AGIO $52.00
- AVG Volume (30 Days)
- ROIC 695.5K
- AGIO 654.8K
- Earning Date
- ROIC 10-22-2024
- AGIO 10-31-2024
- Dividend Yield
- ROIC 3.73%
- AGIO N/A
- EPS Growth
- ROIC N/A
- AGIO N/A
- EPS
- ROIC 0.27
- AGIO N/A
- Revenue
- ROIC $335,046,000.00
- AGIO $31,306,000.00
- Revenue This Year
- ROIC N/A
- AGIO $44.80
- Revenue Next Year
- ROIC $2.43
- AGIO $174.95
- P/E Ratio
- ROIC $58.90
- AGIO N/A
- Revenue Growth
- ROIC 4.84
- AGIO 55.39
- 52 Week Low
- ROIC $10.99
- AGIO $19.80
- 52 Week High
- ROIC $16.20
- AGIO $53.29
- Technical
- Relative Strength Index (RSI)
- ROIC 64.26
- AGIO 52.72
- Support Level
- ROIC $15.44
- AGIO $40.94
- Resistance Level
- ROIC $16.15
- AGIO $42.78
- Average True Range (ATR)
- ROIC 0.23
- AGIO 1.56
- MACD
- ROIC 0.03
- AGIO 0.19
- Stochastic Oscillator
- ROIC 90.70
- AGIO 66.67
About ROIC Retail Opportunity Investments Corp. (MD)
Retail Opportunity Investments Corp is a self-managed real estate investment trust. The company specializes in the acquisition, ownership and management of necessity-based community and neighborhood shopping centers on the west coast of the United States, anchored by supermarkets and drugstores. The Company's primary business is the ownership, management, and redevelopment of retail real estate properties.
About AGIO Agios Pharmaceuticals Inc.
Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development plan for Agios' product candidates includes a precision approach with initial study designs that allow for genetically or biomarker-defined patient populations. The company seeks the potential for proof of concept early in clinical development, along with any potential for accelerated approval.